Divalproex Sodium Delayed-Release Tablets recall: Labeling Error
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith…
Why was Divalproex Sodium Delayed-Release Tablets recalled?
Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 310162, Exp 09/14
- Product
- Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith…
- Recalling firm
- Upsher Smith Laboratories, Inc.
- Quantity
- 11,316 bottles
- Distribution
- Nationwide and Puerto Rico
- Recall date
- January 23, 2013
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)